Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma
Tóm tắt
Studies on gastrointestinal symptoms, dysfunctions, and neurological disorders in systemic scleroderma are lacking so far. Thirty-eight scleroderma patients (34 limited, 4 diffuse), 60 healthy controls and 68 dyspeptic controls were scored for upper and lower gastrointestinal symptoms (dyspepsia, bowel habits), gastric and gallbladder emptying to liquid meal (functional ultrasonography) and small bowel transit (H2-breath test). Autonomic nerve function was assessed by cardiovascular tests. The score for dyspepsia (mainly gastric fullness) was greater in scleroderma patients than healthy controls, but lower than dyspeptic controls who had multiple symptoms, instead. Scleroderma patients with dyspepsia had a longer disease duration. Fasting antral area and postprandial antral dilatation were smaller in scleroderma patients than dyspeptic and healthy controls. Gastric emptying was delayed in both scleroderma patients (particularly in those with abnormal dyspeptic score) and dyspeptic controls, who also showed a larger residual area. Despite gallbladder fasting and postprandial volumes were comparable across the three groups, gallbladder refilling appeared delayed in dyspeptic controls and mainly dependent on delayed gastric emptying in scleroderma. Small intestinal transit was also delayed in 74% of scleroderma and 66% of dyspeptic controls. Bowel habits were similar among the three groups. Autonomic neuropathy was not associated with dyspepsia, gastric and gallbladder motility and small intestinal transit. In scleroderma patients dyspepsia (mainly gastric fullness), restricted distension of the gastric antrum and diffuse gastrointestinal dysmotility are frequent features. These defects are independent from the occurrence of autonomic neuropathy.
Tài liệu tham khảo
Steen VD, Medsger TA: Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am. 1990, 16: 1-10.
Medsger TA: Epidemiology of systemic sclerosis. Clin Dermatol. 1994, 12: 207-216. 10.1016/S0738-081X(94)90323-9.
Artlett CM, Smith JB, Jimenez SA: Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med. 1998, 338: 1186-1191. 10.1056/NEJM199804233381704.
LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988, 15: 202-205.
Sjogren RW: Gastrointestinal motility disorders in scleroderma. Arthritis Rheum. 1994, 37: 1265-1282. 10.1002/art.1780370902.
Battle WM, Snape WJ, Wright S, Sullivan MA, Cohen S, Meyers A, Tuthill R: Abnormal colonic motility in progressive systemic sclerosis. Ann Intern Med. 1981, 94: 749-752.
Bortolotti M, Turba E, Tosti A, Sarti P, Brunelli F, Del Campo L, Barbara L: Gastric emptying and interdigestive antroduodenal motility in patients with esophageal scleroderma. Am J Gastroenterol. 1991, 86: 743-747.
Franck-Larsson K, Hedenstrom H, Dahl R, Ronnblom A: Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity. Scand J Rheumatol. 2003, 32: 348-355. 10.1080/03009740410005016.
Lock G, Holstege A, Lang B, Scholmerich J: Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol. 1997, 92: 763-771.
Maddern GJ, Horowitz M, Jamieson GG, Chatterton BE, Collins PJ, Roberts-Thomson P: Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis. Gastroenterology. 1984, 87: 922-926.
Marie I, Levesque H, Ducrotte P, Courtois H: [Involvement of the small intestine in systemic scleroderma]. Rev Med Interne. 1999, 20: 504-513.
Pedersen J, Gao C, Egekvist H, Bjerring P, Arendt-Nielsen L, Gregersen H, Drewes AM: Pain and biomechanical responses to distention of the duodenum in patients with systemic sclerosis. Gastroenterology. 2003, 124: 1230-1239. 10.1016/S0016-5085(03)00265-8.
Sjogren RW: Gastrointestinal features of scleroderma. Curr Opin Rheumatol. 1996, 8: 569-575. 10.1097/00002281-199611000-00012.
Wang SJ, Lan JL, Chen DY, Chen YH, Hsieh TY, Lin WY: Colonic transit disorders in systemic sclerosis. Clin Rheumatol. 2001, 20: 251-254. 10.1007/s100670170038.
Wegener M, Adamek RJ, Wedmann B, Jergas M, Altmeyer P: Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci. 1994, 39: 2209-2215. 10.1007/BF02090373.
Weston S, Thumshirn M, Wiste J, Camilleri M: Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol. 1998, 93: 1085-1089. 10.1111/j.1572-0241.1998.00334.x.
Nikou GC, Toumpanakis C, Katsiari C, Charalambopoulos D, Sfikakis PP: Treatment of small intestinal disease in systemic sclerosis with octreotide: a prospective study in seven patients. J Clin Rheumatol. 2007, 13: 119-123. 10.1097/RHU.0b013e3180645d2a.
Cerinic MM, Generini S, Pignone A, Casale R: The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms. Rheum Dis Clin North Am. 1996, 22: 879-892. 10.1016/S0889-857X(05)70306-9.
Iovino P, Valentini G, Ciacci C, De Luca A, Tremolaterra F, Sabbatini F, Tirri E, Mazzacca G: Proximal stomach function in systemic sclerosis: relationship with autonomic nerve function. Dig Dis Sci. 2001, 46: 723-730. 10.1023/A:1010779729184.
Lock G, Straub RH, Zeuner M, Antoniou E, Holstege A, Scholmerich J, Lang B: Association of autonomic nervous dysfunction and esophageal dysmotility in systemic sclerosis. J Rheumatol. 1998, 25: 1330-1335.
Malandrini A, Selvi E, Villanova M, Berti G, Sabadini L, Salvadori C, Gambelli S, De Stefano R, Vernillo R, Marcolongo R, et al: Autonomic nervous system and smooth muscle cell involvement in systemic sclerosis: ultrastructural study of 3 cases. J Rheumatol. 2000, 27: 1203-1206.
Straub RH, Zeuner M, Lock G, Rath H, Hein R, Scholmerich J, Lang B: Autonomic and sensorimotor neuropathy in patients with systemic lupus erythematosus and systemic sclerosis. J Rheumatol. 1996, 23: 87-92.
Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, Choquette D, Raymond Y, Senecal JL: Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum. 2001, 44: 735-736. 10.1002/1529-0131(200103)44:3<735::AID-ANR125>3.0.CO;2-F.
Buckley MJ, Scanlon C, McGurgan P, O'Morain C: A validated dyspepsia symptom score. Ital J Gastroenterol Hepatol. 1997, 29: 495-500.
Portincasa P, Moschetta A, Baldassarre G, Altomare DF, Palasciano G: Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting the Rome II criteria for irritable bowel. World J Gastroenterology. 2003, 9 (10): 2293-2299.
Portincasa P, Moschetta A, Berardino M, Di Ciaula A, Vacca M, Baldassarre G, Pietrapertosa A, Cammarota R, Tannoia N, Palasciano G: Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults. World J Gastroenterol. 2004, 10: 2383-2390.
Portincasa P, Altomare DF, Moschetta A, Baldassarre G, Di Ciaula A, Venneman NG, Rinaldi M, Vendemiale G, Memeo V, vanBerge-Henegouwen GP, et al: The effect of acute oral erythromycin on gallbladder motility and on upper gastrointestinal symptoms in gastrectomized patients with and without gallstones: a randomized, placebo-controlled ultrasonographic study. Am J Gastroenterol. 2000, 95: 3444-3451. 10.1111/j.1572-0241.2000.03282.x.
Hveem K, Jones KL, Chatterton BE, Horowitz M: Scintigraphic measurement of gastric emptying and ultrasonographic assessment of antral area: relation to appetite. Gut. 1996, 38: 816-821. 10.1136/gut.38.6.816.
Drewes AM, Schipper KP, Dimcevski G, Petersen P, Andersen OK, Gregersen H, Arendt-Nielsen L: Multimodal assessment of pain in the esophagus: a new experimental model. Am J Physiol Gastrointest Liver Physiol. 2002, 283: G95-G103.
Heaton KW, O'Donnell LJ: An office guide to whole-gut transit time. Patients' recollection of their stool form. J Clin Gastroenterol. 1994, 19: 28-30. 10.1097/00004836-199407000-00008.
O'Donnell MR, Virjee J, Heaton KW: Detection of pseudo diarrhoea by simple assessment of intestinal transit rate. Br Med J. 1990, 300: 439-440.
Bolondi L, Bortolotti MSV, Calleti T, Gaiani S, Labo' G: Measurement of gastric emptying by real-time ultrasonography. Gastroenterology. 1985, 89: 752-759.
Portincasa P, Colecchia A, Di Ciaula A, Larocca A, Muraca M, Palasciano G, Roda E, Festi D: Standards for diagnosis of gastrointestinal motility disorders. Ultrasonography. Dig Liver Dis (Ital J Gastroenterol). 2000, 32 (2): 160-172. 10.1016/S1590-8658(00)80404-1.
Wedmann B, Schmidt G, Wegener M, Coenen C, Ricken D, Althoff J: Effects of age and gender on fat-induced gallbladder contraction and gastric emptying of a caloric liquid meal: a sonographic study. Am J Gastroenterol. 1991, 86: 1765-1770.
Everson GT, Braverman DZ, Johnson ML, Kern F: A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology. 1980, 79: 40-46.
Portincasa P, Di Ciaula A, Baldassarre G, Palmieri VO, Gentile A, Cimmino A, Palasciano G: Gallbladder motor function in gallstone patients: sonographic and in vitro studies on the role of gallstones, smooth muscle function and gallbladder wall inflammation. J Hepatol. 1994, 21: 430-440. 10.1016/S0168-8278(05)80324-1.
Portincasa P, Moschetta A, Colecchia A, Festi D, Palasciano G: Measurement of gallbladder motor function by ultrasonography: towards for standardization. Dig Liver Dis (già Ital J Gastroenterol Hepatol). 2003, 35 (Suppl 3): S56-S61.
Altomare DF, Portincasa P, Rinaldi M, Di Ciaula A, Martinelli E, Amoruso AC, Palasciano G, Memeo V: Slow-transit constipation: a solitary symptom of a systemic gastrointestinal disease. Dis Colon Rectum. 1999, 42: 231-240. 10.1007/BF02237134.
Corazza GR, Strocchi A, Gasbarrini G: Fasting breath hydrogen in celiac disease. Gastroenterology. 1987, 93: 53-58.
Payne DL, Welsh JD, Claypool PL: Breath hydrogen (H2) response to carbohydrate malabsorption after exercise. J Lab Clin Med. 1983, 102: 147-150.
Rosenthal A, Solomons NW: Time-course of cigarette smoke contamination of clinical hydrogen breath-analysis tests. Clin Chem. 1983, 29: 1980-1981.
Stotzer PO, Kilander AF: Comparison of the 1-gram (14)C-D-xylose breath test and the 50-gram hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth. Digestion. 2000, 61: 165-171. 10.1159/000007753.
Pimentel M, Chow EJ, Lin HC: Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000, 95: 3503-3506. 10.1111/j.1572-0241.2000.03368.x.
Pimentel M, Wallace D, Hallegua D, Chow E, Kong Y, Park S, Lin HC: A link between irritable bowel syndrome and fibromialgia may be related to finding on lactulose breath testing. Ann Rheum Dis. 2004, 63: 450-452. 10.1136/ard.2003.011502.
Ryder RE, Marshall R, Johnson K, Ryder AP, Owens DR, Hayes TM: Acetylcholine sweatspot test for autonomic denervation. Lancet. 1988, 1: 1303-1305. 10.1016/S0140-6736(88)92120-4.
Altomare D, Pilot MA, Scott M, Williams N, Rubino M, Ilincic L, Waldron D: Detection of subclinical autonomic neuropathy in constipated patients using a sweat test. Gut. 1992, 33: 1539-1543. 10.1136/gut.33.11.1539.
Vespasiani G, Bruni M, Meloncelli I, Clementi L, Amoretti R, Branca S, Carinci F, Lostia S, Nicolucci A, Romagnoli F, et al: Validation of a computerised measurement system for guided routine evaluation of cardiovascular autonomic neuropathy. Comput Methods Programs Biomed. 1996, 51: 211-216. 10.1016/S0169-2607(96)01774-9.
Rangari M, Sinha S, Kapoor D, Mohan JC, Sarin SK: Prevalence of autonomic dysfunction in cirrhotic and noncirrhotic portal hypertension. Am J Gastroenterol. 2002, 97: 707-713. 10.1111/j.1572-0241.2002.05551.x.
Armitage P, Berry G: Statistical methods in medical research. 1994, Oxford: Blackwell Science Ltd
Dawson B, Trapp RG: Basic & Clinical Biostatistics. 2001, New York: McGraw-Hill
Ibba-Manneschi L, Del RA, Pacini S, Tani A, Bechi P, Matucci CM: Ultrastructural study of the muscle coat of the gastric wall in a case of systemic sclerosis. Ann Rheum Dis. 2002, 61: 754-756. 10.1136/ard.61.8.754.
Manetti M, Neumann E, Milia AF, Tarner IH, Bechi P, Matucci-Cerinic M, Ibba-Manneschi L, Muller-Ladner U: Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients. Arthritis Rheum. 2007, 56: 3442-3447. 10.1002/art.22940.
Quigley EM: Review article: gastric emptying in functional gastrointestinal disorders. Aliment Pharmacol Ther. 2004, 20 (Suppl 7): 56-60. 10.1111/j.1365-2036.2004.02186.x.
Greydanus MP, Camilleri M: Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology. 1989, 96: 110-115.
Marie I, Levesque H, Ducrotte P, Denis P, Hellot MF, Benichou J, Cailleux N, Courtois H: Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol. 2001, 96: 77-83. 10.1111/j.1572-0241.2001.03353.x.
Marycz T, Muehldorfer SM, Gruschwitz MS, Katalinic A, Herold C, Ell C, Hahn EG: Gastric involvement in progressive systemic sclerosis: electrogastrographic and sonographic findings. Eur J Gastroenterol Hepatol. 1999, 11: 1151-1156. 10.1097/00042737-199910000-00013.
Pfaffenbach B, Adamek RJ, Hagemann D, Busch S, Hoffmann K, Altmeyer P, Schaffstein J, Wegener M: Effect of progressive systemic sclerosis on antral myoelectrical activity and gastric emptying. Z Gastroenterol. 1996, 34: 517-521.
Sridhar KR, Lange RC, Magyar L, Soykan I, McCallum RW: Prevalence of impaired gastric emptying of solids in systemic sclerosis: diagnostic and therapeutic implications. J Lab Clin Med. 1998, 132: 541-546. 10.1016/S0022-2143(98)90133-0.
Wedmann B, Wegener M, Adamek RJ, el Gammal S: Gastrobiliary motility after liquid fatty meal in progressive systemic sclerosis. A sonographic study. Dig Dis Sci. 1994, 39: 565-570. 10.1007/BF02088344.
Gregersen H, Liao D, Pedersen J, Drewes AM: A new method for evaluation of intestinal muscle contraction properties: studies in normal subjects and in patients with systemic sclerosis. Neurogastroenterol Motil. 2007, 19: 11-19. 10.1111/j.1365-2982.2006.00837.x.
Rees WD, Leigh RJ, Christofides ND, Bloom SR, Turnberg LA: Interdigestive motor activity in patients with systemic sclerosis. Gastroenterology. 1982, 83: 575-580.
Samsom M, Verhagen MA, vanBerge Henegouwen GP, Smout AJ: Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology. 1999, 116: 515-520. 10.1016/S0016-5085(99)70171-X.
Camilleri M, Talley NJ: Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil. 2004, 16: 135-142. 10.1111/j.1365-2982.2004.00516.x.
Wang SJ, Lan JL, Lan JL, Chen DY, Chen YH, Hsieh TY, Lin WY: Effects of cisapride on colonic transit in patients with progressive systemic sclerosis. Clin Rheumatol. 2002, 21: 271-274. 10.1007/s100670200072.
Sallam H, McNearney TA, Chen JD: Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther. 2006, 23: 691-712. 10.1111/j.1365-2036.2006.02804.x.
Colecchia A, Sandri L, Staniscia T, Vestito A, Capodicasa S, Portincasa P, Mazzella G, Roda E, Festi D: Gallbladder motility and functional gastrointestinal disorders. Dig Liver Dis. 2003, 35 (Suppl 3): S30-S34. 10.1016/S1590-8658(03)00091-4.
Jonderko G, Koterla W, Konca A, Kucharz EJ, Golab T, Rubisz Brzezinska J, Jedrocha W, Marcisz C: [Volume of the functioning gallbladder and its emptying in patients with progressive systemic sclerosis]. Pol Arch Med Wewn. 1993, 89: 298-303.
Lock G, Zeuner M, Kammerl M, Lang B, Scholmerich J, Holstege A: Gallbladder motility in systemic sclerosis. Rheumatol Int. 1996, 16: 61-65. 10.1007/BF01816437.
Posthuma WF, Ledeboer M, Masclee AA, Dijkmans BA, Westendorp RG, Jebbink MC, Breedveld FC, Lamers CB: Do patients with systemic sclerosis have abnormal gallbladder function?. Eur J Gastroenterol Hepatol. 1997, 9: 675-677.
D'Angelo WA, Fries JF, Masi AT, Shulman LE: Pathologic observations in systemic sclerosis (scleroderma). Am J Med. 1969, 46: 428-440. 10.1016/0002-9343(69)90044-8.
Moschetta A, Stolk MF, Rehfeld JF, Portincasa P, Slee PH, Koppeschaar HP, van Erpecum KJ, vanBerge-Henegouwen GP: Severe impairment of postprandial cholecystokinin release and gall- bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR. Aliment Pharmacol Ther. 2001, 15: 181-185. 10.1046/j.1365-2036.2001.00924.x.
Goldblatt F, Gordon TP, Waterman SA: Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology. 2002, 123: 1144-1150. 10.1053/gast.2002.36057.
Stacher G, Merio R, Budka C, Schneider C, Smolen J, Tappeiner G: Cardiovascular autonomic function, autoantibodies, and esophageal motor activity in patients with systemic sclerosis and mixed connective tissue disease. J Rheumatol. 2000, 27: 692-697.
Dantas RO, Villanova MG, de Godoy RA: Esophageal dysfunction in patients with progressive systemic sclerosis and mixed connective tissue diseases. Arq Gastroenterol. 1985, 22: 122-126.
Marie I, Levesque H, Ducrotte P, Denis P, Benichou J, Hellot MF, Cailleux N, Le LX, Joly P, Lauret P, et al: Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study. Arthritis Rheum. 1998, 41: 1874-1883. 10.1002/1529-0131(199810)41:10<1874::AID-ART21>3.0.CO;2-T.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-230X/8/7/prepub